Bladder Cancer in a Patient on Long-term Haemodialysis

Overview

Journal Int Urol Nephrol

Publisher Springer

Specialty Nephrology

Date 1999 Feb 6

PMID 9934798

Citations 1

Authors

H Hadatsuki

I Sasagawa

H Suzuki

H Yaguchi

A Mutoh

Y Kubota

T Nakada

Affiliations

Soon will be listed here.

Abstract

We report a case of bladder cancer on long-term haemodialysis. The relationship between bladder cancer and haemodialysis, and the necessity of periodic cytology of bladder washing are discussed.

Citing Articles

Treatment strategy for bladder cancer in patients on hemodialysis: a clinical review of 28 cases.

Sato Y, Kondo T, Takagi T, Junpei I, Tanabe K Int Urol Nephrol. 2016; 48(4):503-9.

PMID: 26759324 DOI: 10.1007/s11255-015-1199-2.

References

Sasagawa I, Terasawa Y, Imai K, Sekino H, Takahashi H . Acquired cystic disease of the kidney and renal carcinoma in haemodialysis patients: ultrasonographic evaluation. Br J Urol. 1992; 70(3):236-9. DOI: 10.1111/j.1464-410x.1992.tb15723.x. View

Murakami S, Igarashi T, Hara S, Shimazaki J . Strategies for asymptomatic microscopic hematuria: a prospective study of 1,034 patients. J Urol. 1990; 144(1):99-101. DOI: 10.1016/s0022-5347(17)39379-5. View

Robles N, Calero R, Rengel M, Valderrabano F . Hemodialysis and cancer. Nephron. 1990; 54(3):271-2. DOI: 10.1159/000185871. View

Jacobs C, Reach I, Degoulet P . Cancer in patients on hemodialysis. N Engl J Med. 1979; 300(22):1279-80. View

Varkarakis M, Gaeta J, Moore R, Murphy G . Superficial bladder tumor. Aspects of clinical progression. Urology. 1974; 4(4):414-20. DOI: 10.1016/0090-4295(74)90010-7. View

Matas A, Simmons R, Kjellstrand C, Buselmeier T, Najarian J . Increased incidence of malignancy during chronic renal failure. Lancet. 1975; 1(7912):883-6. DOI: 10.1016/s0140-6736(75)91684-0. View

Lindner A, Farewell V, Sherrard D . High incidence of neoplasia in uremic patients receiving long-term dialysis. Cancer and long-term dialysis. Nephron. 1981; 27(6):292-6. DOI: 10.1159/000182073. View

Curtis J . Cancer and patients with end-stage renal failure. Br Med J (Clin Res Ed). 1982; 284(6309):69-70. PMC: 1495692. DOI: 10.1136/bmj.284.6309.69. View

Goldblum S, REED W . Host defenses and immunologic alterations associated with chronic hemodialysis. Ann Intern Med. 1980; 93(4):597-613. DOI: 10.7326/0003-4819-93-4-597. View

10.

Sasagawa I, Nakada T, Kubota Y, Suzuki H, Sawamura T . Serum level of immunosuppressive acidic protein in haemodialysis patients with or without renal cell carcinoma. Br J Urol. 1994; 73(4):355-7. DOI: 10.1111/j.1464-410x.1994.tb07595.x. View

11.

Slifkin R, Goldberg J, Neff M, Baez A, Mattoo N, Gupta S . Malignancy in end-stage renal disease. Trans Am Soc Artif Intern Organs. 1977; 23:34-40. DOI: 10.1097/00002480-197700230-00010. View

12.

Dunnill M, Millard P, Oliver D . Acquired cystic disease of the kidneys: a hazard of long-term intermittent maintenance haemodialysis. J Clin Pathol. 1977; 30(9):868-77. PMC: 476578. DOI: 10.1136/jcp.30.9.868. View